Inside every stressed cell, a quiet emergency response unfolds. When oxygen runs low, toxins accumulate, or nutrients grow scarce, mammalian cells assemble temporary structures known as stress granules, non-membranous aggregates of proteins and RNA that condense in the cytoplasm. In healthy tissue, these assemblies act as a protective pause button, halting protein production so the cell can weather the storm and resume normal function once conditions improve. But a new study suggests that in oral squamous cell carcinoma, one of the most common and disfiguring malignancies of the head and neck, this ancient survival machinery may be hijacked to serve a darker purpose: helping tumors grow and spread.

The research, conducted by a team at Kangwon National University in South Korea and published in Cell Death Discovery, examined how stress granule formation influences tumor progression and metastasis in oral squamous cell carcinoma, or OSCC. The findings point to a specific molecular switch, the phosphorylation of a protein called eIF2α, as a central driver of the process. When that switch is suppressed, the study reports, stress granule formation drops, and with it the growth and metastatic burden of tumors in mouse models. The work adds oral cancer to a growing list of malignancies in which the integrated stress response appears to fuel, rather than restrain, disease.

To understand why this matters, it helps to consider what stress granules actually do. Under stress, cells activate kinases that phosphorylate eIF2α, the alpha subunit of a translation initiation factor. Phosphorylated eIF2α dampens global protein synthesis, and the messenger RNAs that would otherwise be translated are instead sequestered, along with RNA-binding proteins, into dense cytoplasmic droplets. Key markers of these structures include G3BP1, TIAR, and PABP, proteins that researchers use to identify stress granules under the microscope. In normal cells, this translational arrest conserves energy and prevents the accumulation of damaged or misfolded proteins. The system is meant to be reversible: when the stress passes, the granules dissolve and translation restarts.

Cancer cells, however, live in a state of chronic stress. Tumors outgrow their blood supply, creating regions of hypoxia, low oxygen tension that would kill most normal cells. They also face nutrient deprivation, acidic microenvironments, and assault from chemotherapy and radiation. In this context, the stress response can become a liability for the patient rather than a safeguard for the cell. Previous work in other cancers has implicated stress granules in tumor progression and metastasis, partly through their interactions with key signaling pathways, but their role in oral squamous cell carcinoma had remained poorly understood, despite growing scientific interest in the topic.

The Korean team began by comparing human tumor tissue with adjacent normal tissue. They found that markers of stress granules, including G3BP1, eIF2α, TIAR, and PABP, were significantly overexpressed in OSCC tissues compared with their normal counterparts. This observation established that the stress granule machinery is not merely present in oral cancer but is amplified, suggesting that tumor cells may rely on it more heavily than the healthy cells around them. Overexpression of these markers alone does not prove causation, but it set the stage for the functional experiments that followed.

Those experiments turned to mouse models built from OSCC cells that had been preconditioned with hypoxia, deliberately exposing the cells to low oxygen before implantation. The logic was to mimic the stressful conditions tumor cells encounter in a real growing tumor and to ask whether cells that had already mounted a stress response behaved differently afterward. In parallel, the researchers used a compound called ISRIB, an inhibitor of the integrated stress response that acts downstream of eIF2α phosphorylation, in mice subjected to sodium arsenite-induced stress. Sodium arsenite is a classic laboratory trigger of oxidative stress and a reliable inducer of stress granule formation, making it a useful tool for probing the pathway.

The results were striking. In both experimental settings, suppression of eIF2α phosphorylation was associated with reduced stress granule formation, reduced tumor growth, and a reduced metastatic burden. In other words, when the researchers blocked the molecular event that nucleates stress granules, the tumors not only grew more slowly but also spread less aggressively. Conversely, the study found that stress granule formation was elevated during hypoxia-induced stress, underscoring a stress-responsive regulatory mechanism in which the harsh conditions of the tumor microenvironment actively promote the assembly of these granules. Together, the data sketch a coherent chain of causation: hypoxia and other stresses trigger eIF2α phosphorylation, phosphorylation drives stress granule assembly, and the granules support the cellular programs that allow OSCC cells to proliferate and colonize distant sites.

Why would a structure designed to protect cells become an engine of metastasis? The authors and other researchers in the field point to the selective nature of stress granules. While global translation is arrested, certain messenger RNAs are preferentially stored within the granules and protected from degradation. Among the transcripts sheltered this way are often those encoding proteins that promote survival, invasion, and epithelial-to-mesenchymal transition, the process by which stationary epithelial cancer cells acquire the motility needed to invade surrounding tissue and enter the bloodstream. By acting as temporary warehouses for pro-metastatic messages, stress granules may allow tumor cells to stockpile the tools of aggression, releasing them for translation once the acute stress subsides. In this view, the granule is not merely a damage-control structure but a staging ground for the next phase of tumor progression.

The therapeutic implications are considerable. Oral squamous cell carcinoma is frequently diagnosed at advanced stages, and metastasis to cervical lymph nodes is one of the strongest predictors of poor outcome. Existing treatments, surgery, radiation, and chemotherapy, remain limited in their ability to control disseminated disease. If stress granule formation genuinely drives metastatic behavior, then the pathway offers a new target. ISRIB, the compound used in the mouse experiments, has attracted attention in recent years for its ability to blunt the integrated stress response, and the new findings suggest that agents with a similar mechanism could be explored as anti-metastatic therapies in oral cancer. The authors conclude that stress granules promote OSCC progression via eIF2α phosphorylation and might serve as a novel therapeutic target, a formulation that is deliberately cautious but clinically suggestive.

As with any preclinical study, important caveats apply. The evidence comes from human tissue comparisons and mouse models, and translating these findings into patients will require further work to confirm that the same mechanism operates in human tumors in real time, to identify which patient subsets have the highest stress granule activity, and to develop inhibitors with acceptable safety profiles. Suppressing a fundamental cellular stress pathway carries risks, since normal tissues also rely on the integrated stress response during injury and inflammation. Still, the study fills a genuine gap in the literature by connecting a well-characterized cellular stress mechanism to one of the most clinically feared behaviors of oral cancer. It also adds to a broader shift in cancer biology: the recognition that tumors are not just collections of mutated genes but ecosystems shaped by physical and chemical stress, and that the survival programs cells use to endure hardship can be turned against the organism that hosts them. For patients with oral squamous cell carcinoma, whose disease too often spreads before it can be stopped, the humble stress granule may prove to be an unexpected and consequential adversary.

Subject of Research: The role of stress-induced eIF2α phosphorylation and stress granule formation in promoting metastasis of oral squamous cell carcinoma

Article Title: Stress-induced eIF2α phosphorylation promotes tumor metastasis in oral squamous cell carcinoma

Article References: Kim, S., Park, S., Lee, Y., Park, G., & Choi, J. (2026). Stress-induced eIF2α phosphorylation promotes tumor metastasis in oral squamous cell carcinoma. Cell Death Discovery. https://doi.org/10.1038/s41420-026-03412-4

Image Credits: AI Generated

DOI: 10.1038/s41420-026-03412-4

Keywords: stress granules, eIF2α phosphorylation, oral squamous cell carcinoma, metastasis, integrated stress response, ISRIB, hypoxia, G3BP1, tumor progression, translational arrest, cancer biology, therapeutic target

The viruses that gave rise to SARS-CoV-2 have been circulating in horseshoe bats and related mammals across Asia for millennia, and most of them have never spilled over into people. Yet a small number of these bat sarbecoviruses clearly can infect humans, as the COVID-19 pandemic demonstrated. A central question for pandemic preparedness has therefore been whether scientists can look at the properties of a newly discovered bat coronavirus and make an evidence-based judgement about how dangerous it might be. A new study published in PLOS Biology suggests that one measurable property, the breadth of species whose ACE2 receptor a virus can use, may be a surprisingly informative signal, predicting not only which animals a virus can infect but also how closely related it is to SARS-CoV-2 in the eyes of the human immune system.

Sarbecoviruses, the subgenus of coronaviruses that includes SARS-CoV and SARS-CoV-2, attach to their host cells through the receptor-binding domain, or RBD, of the Spike protein. This domain grips the angiotensin-converting enzyme 2 receptor, ACE2, on the surface of host cells, and it is also the principal target of neutralising antibodies. That dual role creates an intimate link between host range and antigenicity: the same molecular surface that determines which species’ receptors a virus can engage also determines how well antibodies raised against one virus recognise another. The research team, led by scientists at The Pirbright Institute together with collaborators including researchers at King’s College London, set out to map that relationship systematically across a diverse collection of bat sarbecoviruses.

The experimental strategy combined three complementary approaches. First, the researchers used binding assays to test whether the Spike proteins of different sarbecoviruses could attach to ACE2 proteins from a wide panel of mammalian species. Second, they used pseudotype-entry assays, in which harmless lentiviral particles are decorated with each coronavirus Spike protein, to test whether receptor binding actually translates into cell entry. Third, they measured how sera from SARS-CoV-2 convalescent individuals and monoclonal antibodies from vaccinated people who had experienced breakthrough infections neutralised the different viruses. By running the same viruses through all three assays, the team could directly correlate receptor usage with antigenic behaviour.

The results revealed a striking pattern. Sarbecoviruses in clade 1, the group that contains SARS-CoV-2 itself and the BANAL viruses isolated from bats in Laos, tended to be generalists. Their Spike proteins could productively engage ACE2 receptors from many different bat species, indicating that they are not finely tuned to a single host. In contrast, viruses from clade 3, exemplified by RhGB07, and clade 5, exemplified by Rc-o319, behaved as specialists, using a much narrower range of ACE2 receptors. Rc-o319, which was previously known to be unable to use human ACE2 efficiently, fits this specialist profile, whereas the BANAL viruses, which can use human ACE2, sit firmly in the generalist camp alongside SARS-CoV-2.

To understand the structural basis of this specialism, the team solved a novel structure of the RhGB07 Spike protein. The structure allowed them to identify specific residues within the RBD that are associated with the restricted receptor usage of this clade 3 virus. These residues presumably shape the receptor-binding interface in ways that favour particular bat ACE2 variants while excluding others. Such structural insights are valuable because they point to the molecular features that distinguish viruses capable of flexible receptor engagement from those locked into narrow host ranges, and they may help predict the properties of newly discovered sarbecoviruses from sequence data alone.

When the researchers extended their receptor panel beyond bats to include more diverse mammalian ACE2 proteins, the generalist phenotype largely held. Clade 1 viruses could bind and enter cells expressing ACE2 from humans, non-human primates, livestock, and rodents, as well as from species considered potential intermediate reservoir hosts, such as civets, raccoon dogs, and pangolins. This is significant because intermediate hosts are thought to have played a role in previous coronavirus spillovers, including the emergence of SARS-CoV in 2002. A virus that can already use the receptors of many species faces fewer barriers on the path from bat to human. The specialist viruses, by contrast, showed wider phenotypic diversity across this expanded panel, with RhGB07 exhibiting a more idiosyncratic pattern of receptor usage that did not simply mirror its bat-host profile.

The study also examined how SARS-CoV-2’s ongoing evolution in humans has changed its receptor preferences. Comparing variants that have emerged during the pandemic, the researchers found an expanding and, in some cases, shifting pattern of generalism, particularly for Omicron and its many sub-lineages. Omicron’s Spike has accumulated numerous mutations in the RBD, and these changes appear to have broadened or reconfigured the range of ACE2 molecules the virus can engage. This observation underscores that receptor usage is not a fixed property of a virus but a dynamic trait that can evolve under immune pressure and changing transmission landscapes, with potential consequences for which animal species might serve as new reservoirs for human-derived variants.

The antigenic side of the analysis produced equally important findings. When convalescent sera from people who had recovered from COVID-19 were tested against the panel of bat sarbecoviruses, clade 1 viruses, being phylogenetically closest to SARS-CoV-2, were antigenically the most similar. There was robust evidence for cross-neutralisation of these viruses, meaning that immunity generated against SARS-CoV-2 offers meaningful protection against its closest bat relatives. Importantly, however, the team also found evidence for limited cross-neutralisation across the entire subgenus, suggesting that even the more distantly related specialist viruses are not completely invisible to immunity primed by SARS-CoV-2 infection. This graded pattern of cross-reactivity maps closely onto the phylogenetic and receptor-usage relationships the researchers had established.

Using monoclonal antibodies derived from COVID-19 vaccinees who subsequently experienced breakthrough infections, the researchers were able to pinpoint which classes of antibody epitopes are responsible for the broader neutralisation observed across the sarbecovirus panel. Because antibodies recognise specific structural features of the RBD, identifying the epitope classes that mediate cross-neutralisation provides a rational basis for designing vaccines and therapeutics with deliberately broad coverage. Antibodies directed against more conserved features of the receptor-binding interface, rather than those specific to SARS-CoV-2’s particular configuration, appear to underpin the wider neutralising activity.

Taken together, the study delivers a unifying message: generalist ACE2 usage, phylogenetic proximity to SARS-CoV-2, and antigenic similarity travel together. A bat sarbecovirus that can flexibly use receptors from many mammalian species is likely to be a close relative of SARS-CoV-2 and likely to be partially neutralised by existing human immunity. This constellation of traits offers surveillance teams a practical framework for triage. When a new sarbecovirus is discovered, characterising its receptor-binding breadth through binding and pseudotype assays could provide an early, laboratory-based assessment of both its zoonotic potential and the degree to which current vaccines and antibodies might protect against it. As bat habitats are disturbed and human-wildlife interfaces expand, such tools for distinguishing the generalists from the specialists among the thousands of circulating bat coronaviruses could prove essential for anticipating, and perhaps preventing, the next spillover.

Subject of Research: ACE2 receptor usage breadth as a predictor of host range and antigenic relatedness across bat sarbecoviruses

Article Title: Breadth of ACE2 receptor usage predicts host range and antigenic relatedness across bat sarbecoviruses

Article References: Thakur, N., Newman, J., Ni, D., Seow, J., Hay, A. L., Lee, Y., Upadhyay, A., Ekundayo, B. E., Hammond, J. A., Peacock, T. P., Lau, K., Doores, K. J., & Bailey, D. (2026). Breadth of ACE2 receptor usage predicts host range and antigenic relatedness across bat sarbecoviruses. PLOS Biology, 24(10), e3003944. https://doi.org/10.1371/journal.pbio.3003944

Image Credits: AI Generated

DOI: 10.1371/journal.pbio.3003944

Keywords: sarbecoviruses, ACE2, SARS-CoV-2, host range, receptor-binding domain, antigenicity, cross-neutralisation, bat coronaviruses, zoonotic spillover, Omicron, monoclonal antibodies, pseudotype assays

Imagine trying to listen for a whisper while making a loud noise yourself. An African elephantnose fish faces a similar problem underwater. It sends out small electric pulses to explore its surroundings, but those pulses could drown out the faint signals it needs to detect food and other fish. The fish has sensors in its […]

The post How Electric Fish Tune Out Their Own Signals appeared first on Knowridge Science Report.

You might imagine that the DNA in your cells has a simple history. Even though it’s been recombined in every generation through sex and gained the occasional mutation, on the whole the genome has been stable and has been passed down reliably from your ancestors. But that’s not the entire story. Nearly half of your genome is a wild drama: mobile, repetitive, disruptive, even viral.

Source

Around 700 million years ago, a group of organisms resembling little more than glowing, gelatinous blobs split off from the rest of the animals, forming possibly the earliest branching animal lineage. Nearly 200 species of ctenophores, commonly known as comb jellies (but unrelated to jellyfish), live today in environments ranging from the cold depths of the sea to warm coastal surface waters.

Source

Biofilms are complex microbial communities that adhere to a surface and encase themselves in a viscous matrix they produce. This structure protects bacteria from antibiotics and the immune system far more effectively than if they lived in a free-floating state, making biofilms one of the most common causes of hard-to-treat chronic infections—such as respiratory infections in people with cystic fibrosis and chronic obstructive pulmonary disease (COPD), chronic wounds, or infections associated with catheters and prosthetic devices. Added to this is the global rise in antibiotic resistance, which makes it increasingly urgent to have tools capable of predicting which treatment will work in each case.

The ocean's aphotic zone—the dark, high-pressure region below the surface, where sunlight cannot reach—is home to a vast wealth of microbial life. Yet scientists know relatively little about the genetic makeup, growth and function of many of these enigmatic organisms.

The ocean's aphotic zone—the dark, high-pressure region below the surface, where sunlight cannot reach—is home to a vast wealth of microbial life. Yet scientists know relatively little about the genetic makeup, growth and function of many of these enigmatic organisms.

Researchers at Queen Mary University of London are closer to understanding tendinopathy, a common condition that can cause persistent pain and impaired movement in people and many animals.

The winners of this year’s Nikon Small World in Motion competition showcase the wiggly, feathery, undulating beauty of invisible life.

In recent years, there has been a lot of excitement about the potential for studying human diseases in what are called "organoids." These small patches of tissue, formed using stem cells, appear to produce many of the same cell types and at least some of the structures normally formed in actual organs, and thus can provide a better model for diseases that rely on the sometimes complex interactions among multiple specialized cell types that are a feature of the human body.

But even the most sophisticated organoids lack a lot of the features of a real human body. This is especially true for brain organoids, which don't form any of the connections with specialized brain structures needed to behave "normally." On Wednesday, a research group at Stanford University described a possible way to study brain organoids in a somewhat more natural context: They genetically wiped out a large portion of the mouse brain and replaced it with human brain organoid cells.

The replacements

Organoids, because they adopt a three-dimensional tissue structure and consist of various specialized cells, provide a much better model for an intact tissue than simply having a bunch of disassociated cells lying flat on a culture dish. But they still have a lot of limitations—they're not hooked up to a circulatory system that allows the liver to process chemicals the organoid produces and don't have immune cells moving through them, to give just a couple of examples.

Read full article

Comments

© S. Pasca lab, Stanford University

In recent years, there has been a lot of excitement about the potential for studying human diseases in what are called "organoids." These small patches of tissue, formed using stem cells, appear to produce many of the same cell types and at least some of the structures normally formed in actual organs, and thus can provide a better model for diseases that rely on the sometimes complex interactions among multiple specialized cell types that are a feature of the human body.

But even the most sophisticated organoids lack a lot of the features of a real human body. This is especially true for brain organoids, which don't form any of the connections with specialized brain structures needed to behave "normally." On Wednesday, a research group at Stanford University described a possible way to study brain organoids in a somewhat more natural context: They genetically wiped out a large portion of the mouse brain and replaced it with human brain organoid cells.

The replacements

Organoids, because they adopt a three-dimensional tissue structure and consist of various specialized cells, provide a much better model for an intact tissue than simply having a bunch of disassociated cells lying flat on a culture dish. But they still have a lot of limitations—they're not hooked up to a circulatory system that allows the liver to process chemicals the organoid produces and don't have immune cells moving through them, to give just a couple of examples.

Read full article

Comments

© S. Pasca lab, Stanford University

When you think of viruses, you probably think of flu-like symptoms and quarantines. Humankind has suffered from viral diseases ranging from smallpox to COVID-19, hantavirus and Ebola since the dawn of recorded history.

New experiments reveal a sophisticated posture-control system hidden inside living wood.

Ancient ferns may have helped keep Triassic Europe burning by rapidly regrowing after fires and supplying fresh fuel for the next blaze. Around 201 million years ago, Earth was rocked by the end-Triassic mass extinction. The crisis has been linked to enormous volcanic activity associated with the breakup of Pangea. Those eruptions released huge quantities [...]

Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known as radial glia. These cells help determine which brain cells are produced, when they appear, and how the cerebral cortex, the [...]

Researchers have identified a new plant species in western Thailand whose unusual appearance inspired the dramatic name Thismia daemona, or the “devil flower.” A nearly black flower with horn-like projections and flashes of reddish orange has been discovered beneath leaf litter in a mountain forest in western Thailand. The plant cannot photosynthesize, spends most of [...]

The mammalian gut microbiome teems with a delicate balance of bacteria and the viruses that keep them in check, called bacteriophages, or phages. Each bacterial species usually has its own set of phage partners.

The mammalian gut microbiome teems with a delicate balance of bacteria and the viruses that keep them in check, called bacteriophages, or phages. Each bacterial species usually has its own set of phage partners.

Despite major strides in education and conservation efforts, rabies remains a serious public health issue. The Center for Disease Control (CDC) estimates around 90 percent of cases occur in wildlife, but their consequences still reverberate across ecosystems and routinely endanger humans. Combating the viral disease costs the United States over $300 million every year, but the hefty price tag is justified. Contracting one of the oldest known diseases invariably causes severe symptoms like abnormal sensations, violent movements, hydrophobia, and loss of consciousness. Rabies is fatal in virtually every documented case, and still kills around 59,000 people around the world each year.

Once primarily associated with dogs, rabies has since spread to wildlife such as raccoons, skunks, bats, and foxes—making the issue much more difficult to track and control. Since 1995, the United States Department of Agriculture (USDA) has overseen a National Rabies Management Program in cooperation with state and federal departments, university researchers, and other organizations. After over 30 years of work, one of the most preferred mitigation methods is regularly placing oral rabies vaccine (ORV) bait in strategically selected wildlife areas. The easiest way to spread millions of bait blocks across thousands of square miles? Airdrops.

Next month, the USDA will once again begin tossing fishmeal-coated ORV packets from planes throughout the Southeastern states of Virginia, North Carolina, Tennessee, Georgia, and Alabama. These tiny edibles are specifically crafted to target the most prominent rabies variants seen in raccoons, coyotes, and gray foxes.

“The goal is to prevent westward spread of raccoon rabies by creating a continuous vaccine barrier that stays in front of rabies occurrence on the landscape,” a USDA spokesperson recently told FOX Carolina News. The representative added that although the distribution’s scope doesn’t currently include South Carolina, they are “very close to establishing an ORV area in South Carolina counties bordering North Carolina and Georgia in the next few years.”

If all goes as planned, the National Rabies Management Program’s geographic scope will shrink over time as the disease is regionally eliminated. Until then, anyone who accidentally comes into contact with an ORV bait brick shouldn’t worry about contracting the disease. The vaccine inside each brick is proven safe for over 60 animal species, including cats and dogs. If you happen to locate one in a residential area, the USDA recommends to either simply leave it alone, or use gloves to move it to a more remote location for its intended recipients. Always wash your hands thoroughly after handling ORV bait—and try to ignore the pungent odor of fishmeal.

The post It’s almost time to airdrop rabies vaccines again appeared first on Popular Science.